FindTrial
Sign In

Study to detect Raynaud's phenomenon in a healthy population in the Midwest region of Brazil with assessment of patient's finger circulation through videocapilaroscopy examination

Study of the prevalence of Raynaud's phenomenon in a healthy population in the midwest region of Brazil with morphological and anatomical evaluation of patients' microcirculation through videocapilaroscopy

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
REBEC
Registry ID
RBR-44jkr3
Enrollment
Unknown
Registered
2019-10-30
Start date
2016-02-29
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Raynaud's disease

Interventions

Questionnaire application in 1500 people to detect the presence of possible and defined Raynaud phenomenon. Afterwards, these two groups will be paired with a control group n = 112 (7.5%) for the vide
Other
E05.318.308.980
E01.370.350.515.277.500

Sponsors

Hospital de Base do Distrito Federal
Lead Sponsor
Hospital de Base do Distrito Federal
Collaborator

Eligibility

Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Brazilians; employees of the Federal District Health Department; age 18 to 65 years

Exclusion criteria

Exclusion criteria: over 65 years old; under 18 years old; foreigners; patients with rheumatic connective tissue disease

Design outcomes

Primary

MeasureTime frame
It is expected to find between 3 and 15% of individuals with Raynaud Phenomenon and to identify the characteristics associated with Raynaud Phenomenon through 3 questionnaires for the diagnosis of Raynaud Phenomenon.—

Secondary

MeasureTime frame
It is expected to analyze the differences in the characteristics of the possible and defined Raynaud Phenomenon. ;It is expected to compare the characteristics of the periungual microcirculation of the population with Raynaud's phenomenon and the controls. ;It is expected to evaluate how many will develop any connective tissue disease during the follow-up offered—

Countries

Brazil

Contacts

Public ContactRodrigo;Rodrigo Lima;Lima

FEPECS (Fundação de Ensino e Pesquisa em Ciências da Saúde)/ SES/ DF (SECRETARIA DE ESTADO DE SAÚDE DO DISTRITO FEDERAL); FEPECS (Fundação de Ensino e Pesquisa em Ciências da Saúde)/ SES/ DF (SECRETARIA DE ESTADO DE SAÚDE DO DISTRITO FEDERAL)

rodrigorheuma@hotmail.com;rodrigorheuma@hotmail.com+55 61 999611797;61999696302

Outcome results

None listed

Source: REBEC (via WHO ICTRP)